Airlines stocks took off on Thursday, boosted by Delta reporting better-than-expected earnings and reinstating its full-year ...

The Master Account, in which I am personally invested alongside SMA clients, returned 12.4% net in Q2 2025, compared to 10.9% ...

Learn more› By The Deals Team The Deals team hunts for and highlights only the best discounts on picks made by our editorial ...

What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets Although markets are trying ...

With the season fast approaching, here is our full preview of every wide receiver room in the Big Ten entering 2025.

Not only is the Portable Roku Streaming Device equipped with 4K/HDR/Dolby Vision, but it also features a convenient voice remote and powerful long-range WiFi. If you don’t already own our favorite ...

Although markets are trying to shrug off the week's U.S. tariff threats as yet another negotiation tactic, there's growing ...

The psychiatrist Mark Epstein shares his insights about the mind after decades of working with patients and practicing ...

As a new mom, planning for my daughter’s future is top of mind. Before opening a savings or brokerage account, I asked ...

Carlisle United fans have given their reaction to the News & Star after the Blues' 2025/26 National League fixtures were ...

Carlisle United fans have given their reaction to the News & Star after the Blues' 2025/26 National League fixtures were announced.

Novartis accelerates its protein degrader programmes by licensing a phase 3-ready prostate cancer candidate from Arvinas in a deal worth over $1 billion.